Kidney Cancer UK makes NICE plea
Charity highlights the need to find kidney cancer early and for better guidance among doctors
Read Moreby John Pinching | Feb 6, 2023 | News | 0
Charity highlights the need to find kidney cancer early and for better guidance among doctors
Read Moreby John Pinching | Dec 12, 2022 | News | 0
Organisation believes the guidance would leave renal patients with no effective treatment outside hospital
Read Moreby John Pinching | Nov 18, 2022 | News | 0
The charity commissioned a two-year service quality audit of over 18,000 kidney cancer patients
Read Moreby John Pinching | Jul 18, 2022 | News | 0
The treatment was developed by Calliditas and will be marketed by Stada
Read Moreby John Pinching | May 27, 2022 | News | 0
Initial group of patients have received Saphnelo in a phase 3 trial evaluating lupus nephritis
Read Moreby Selina McKee | May 6, 2020 | News | 0
The guideline is designed to help healthcare professionals who are not kidney specialists to prevent, detect and manage AKI in hospitalised patients with suspected or confirmed COVID-19
Read Moreby Anna Smith | May 2, 2019 | News | 0
AbbVie’s Mavyret treats all six genotypes of hepatitis C virus.
Read Moreby Anna Smith | Mar 18, 2019 | News | 0
New iron-trial results have paved the way for improved haemodialysis treatment.
Read Moreby Selina McKee | Nov 22, 2016 | News | 0
The Royal Free London NHS Foundation Trust and British tech group DeepMind, the artificial intelligence unit of Google, have announced a landmark partnership that aims to transform patient care via a “ground-breaking” new mobile clinical app.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
